Nexalin Technology, Inc. Warrant

NXLIW

...

NXLIW: Nexalin Technology Inc design and develop innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy.

Show NXLIW Financials

All

Government

Consumer Interest

SEC Filings

ESG/Other

Congress Trading

Recent trades of NXLIW by members of U.S. Congress

No Congress Trading data for this ticker

Congress Trading Dashboard

Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by NXLIW's directors and management

No recent Insider Trading for this ticker

Insider Trading Dashboard

Corporate Lobbying

Government lobbying spending instances

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

U.S. Patents

New patents grants

No new patents for this ticker

U.S. Patents Dashboard

Government Contracts

Federal grants, loans, and purchases

No Government Contracts for this ticker

Government Contracts Dashboard

Twitter

Followers on NXLIW's company Twitter account

WallStreetBets

Number of mentions of NXLIW in WallStreetBets Daily Discussion

NXLIW News

Recent insights relating to NXLIW

CNBC Recommendations

Recent picks made for NXLIW stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in NXLIW

Corporate Flights

Flights by private jets registered to NXLIW